Day: March 24, 2025

Actelis Reports Strong Performance in 2024 Driven by Software and Services renewals, Federal and Military Sector Growth, New Product Adoption, and Strategic Cost Management; Gross Margin Expansion to 55% Reflects Success in High-Value Markets as Company Positions for Continued Growth in Three Multi-Billion vertical markets FREMONT, Calif., March 24, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today announced its financial results for the full year 2024, reporting significant improvements across key financial metrics. The company showed strong performance, with revenue growth, improved margins, and continued progress in its strategic market positioning. Key Financial HighlightsMajor...

HONG KONG, March 24, 2025 (GLOBE NEWSWIRE) — Mongolian Mining Corporation (“MMC” or the “Company”, or together with its subsidiaries, the “Group”; stock code: 975), the largest producer and exporter of washed hard coking coal (“HCC”) in Mongolia, today announced its annual results for the year ended 31 December 2024 (“FY2024” or the “Year”). During the Year, the Group’s revenue reached a record high level of USD1,039.9 million (FY2023: USD1,034.8 million). The Group sold a total of 8.6 million tonnes (“Mt”) of coal products in FY2024, comprising of 7.8 Mt of primary products (including 4.7 Mt of HCC), and 0.8 Mt of secondary products. The Group’s average selling price for HCC, excluding applicable VAT in PRC, was USD168.4 per tonne, compared to USD160.2 per tonne during the year ended 31 December 2023. The Group’s gross profit...

Flutter Entertainment publishes historical financial data to reflect 2025 segment reporting changes DUBLIN and TORONTO, March 24, 2025 (GLOBE NEWSWIRE) — Flutter Entertainment (“Flutter”) (NYSE:FLUT, LSE:FLTR), the leading online sports betting and iGaming operator, announced on March 4, 2025 that it is updating its reportable segments to reflect the way the company now manages operations and allocates resources. These changes have no impact on Flutter’s historical consolidated financial position or results. Effective from the first quarter of 2025, Flutter will report two segments:US: comprising the FanDuel brand and unchanged from the US segment as reported in 2024 Flutter International: comprising all other Flutter brands. This will align with previously reported UK & Ireland, Australia and International...

HOUSTON, March 24, 2025 (GLOBE NEWSWIRE) — Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology, infrastructure, and services company, today announced its financial results for the fourth quarter and full-year ended December 31, 2024. Intuitive Machines CEO Steve Altemus said, “Just two years ago, we became a public company with a bold vision for the future. Over the past year, we’ve deliberately positioned ourselves for long-term success by expanding our technical capabilities, opening new revenue streams, and fortifying our financial position. Today, we stand stronger than ever— financially secure, debt-free, and ready to take the next leap.” HighlightsExecuted southernmost ever lunar landing on the South pole region of the Moon and accelerated payload operations for NASA’s...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating respiratory viruses and cancer Updates expected later this year from the MD Anderson Cancer Center (MDACC) investigator-initiated Phase 1/2 clinical trial of seclidemstat in combination with azacitidine to treat hematologic cancers HOUSTON, March 24, 2025 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new treatment options, today reported financial results for the 12 months ended December 31, 2024, and provided a business update. Financial HighlightsNet loss for 2024 was $5.6...

Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate with four confirmed partial responses SAFEbody technology utilized to create masked T cell engagers for potentially superior safety profile with enhanced therapeutic index Cash balance of $85.2 million provides runway into late 2026 SAN DIEGO and SUZHOU, China, March 24, 2025 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel anti-body-based therapies, today reported financial results for the full year 2024 and provided corporate updates. “The clinical data we generated in 2024 with ADG126 gives us great confidence in our ability to provide patients with colorectal cancer a tolerable, efficacious treatment...